Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

Condition:   Patients With Diagnosis of Unresectable or Metastatic Soft Tissue Sarcoma
Interventions:   Drug: Doxorubicin;   Combination Product: L19TNF plus doxorubicin
Sponsor:   Philogen S.p.A.
Not yet recruiting

http://ift.tt/2GOwyHV